I3LUNG - Integrative science, Intelligent data platform for Individualized Lung cancer care with Immunotherapy

I3LUNG is an international, multicenter, retrospective and prospective, observational study of patients with advanced non-small cell lung cancer treated with immunotherapy. Using AI-based tools, the aim of this study is to promote individualized treatment in aNSCLC, with the goals of improving survival and quality of life, minimizing or preventing undue toxicity and promoting efficient resource allocation. The final objective of the project is the construction of a novel, integrated, AI-assisted data storage and elaboration platform to guide IO administration in aNSCLC, ensuring easy access and cost-effective use by healthcare providers and patients.